Multi-analyte monitoring sensor
By setting two working electrodes and enzyme sensing layers on the sensor and covering them with polymer film layers, the problem of long response time for blood ketone detection and inability to monitor blood sugar and blood ketones simultaneously in traditional methods is solved, and blood sugar and blood sugar are achieved. Continuous and high sensitivity monitoring of blood ketones.
Patent Information
- Application Number
- PCT/CN2023/116865
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-25
- Filing Date
- 2023-09-05
- Publication Date
- 2024-11-28
AI Technical Summary
The traditional blood ketone detection method has a long response time and cannot monitor blood sugar and blood ketones at the same time, making it inconvenient to use.
A multi-analyte monitoring sensor is designed, including two working electrodes and an enzyme sensing layer, and a polymer film layer covers the enzyme layer, which can simultaneously pass glucose and ketones, simplify the production process and improve the stability and sensitivity of the sensor.
Continuous monitoring of blood sugar and blood ketones is achieved, the production process is simplified, the sensitivity and accuracy of the sensor is improved, the electric field interference is reduced, and the measurement accuracy is enhanced.
Smart Images

Figure CN2023116865_28112024_PF_FP_ABST
Abstract
Description
Multi-analyte monitoring sensors Technical Field
[0001] The present disclosure relates generally to the field of biosensors, and more particularly to a multi-analyte monitoring sensor. Background Art
[0002] Biosensors are analytical devices that tightly combine biological materials, bio-derived materials, or biomimetic materials with optical, electrochemical, temperature, piezoelectric, magnetic, or micromechanical physical and chemical sensors or sensing microsystems. They can usually be used to quickly detect certain specific chemicals in the human body, such as glucose, ketone bodies, uric acid, and a series of amino acid compounds.
[0003] When blood sugar is too high, the body lacks insulin, or a ketogenic diet is followed, the body will metabolize fat to produce ketone bodies. When the amount of ketone bodies exceeds the metabolic capacity of the liver, complications of diabetes are likely to occur. Therefore, monitoring blood ketone levels is also of great significance in diabetic patients.
[0004] Traditional blood ketone testing methods, including urine ketone test strips, blood ketone test strips, and biochemical analysis, quantitatively or qualitatively measure the levels of β-hydroxybutyrate (β-BHB or hydroxybutyrate), acetone, and acetoacetic acid in blood or urine, thereby reflecting ketone body levels. Wearable acetone sensors typically detect acetone in the exhaled breath of diabetic patients, converting the resistance change into a digital value and sending it to a display module to indicate the acetone concentration.
[0005] However, the response time of the above-mentioned acetone sensor is usually about 50 seconds, and the assessment of acetone usually has a lag; and when it is necessary to monitor blood sugar and blood ketones simultaneously, it is generally necessary to set up an additional blood sugar sensor to monitor blood sugar, which is inconvenient to use.
[0006] Summary of the Invention
[0007] The present disclosure is proposed in view of the above situation, and its object is to provide a multi-analyte monitoring sensor that can continuously monitor blood glucose and blood ketones simultaneously.
[0008] To this end, the present disclosure provides a multi-analyte monitoring sensor, which includes a substrate, a working electrode arranged on the substrate, an enzyme sensing layer arranged on the working electrode, and a polymer film layer arranged on the enzyme sensing layer, wherein the working electrode includes a first working electrode and a second working electrode; the enzyme sensing layer includes a first analyte enzyme layer and a second analyte enzyme layer, the first analyte enzyme layer is arranged on the first working electrode, and the second analyte enzyme layer is arranged on the second working electrode, the first analyte is glucose, and the second analyte is ketone; the polymer film layer is permeable to the first analyte and the second analyte and covers the first analyte enzyme layer and the second analyte enzyme layer.
[0009] In the multi-analyte monitoring sensor involved in the present disclosure, by setting two analyte enzyme layers on the two working electrodes of the sensor, the concentration levels of two different analytes in the tissue fluid can be detected separately; the polymer film layer can simultaneously pass through glucose and ketones, and by covering the first analyte enzyme layer and the second analyte enzyme layer with the polymer film layer, the permeation of the two analytes can be restricted, and at the same time, the stability of the sensor can be improved; in addition, due to the small size of the biosensor, the precision of the film coating on the surface of the sensor is relatively high, and the immersion pulling method is usually used to cover the surface of the sensor with a membrane liquid to form a film layer covering the sensor. Compared with the solution of setting a semipermeable membrane that can pass through glucose and ketones on the first analyte enzyme layer and the second analyte enzyme layer respectively, the polymer film in the present invention can simultaneously pass through glucose and ketones, thereby simplifying the manufacturing process of the sensor while maintaining the high sensitivity and accuracy of the sensor. Thus, a sensor with a simple manufacturing process and capable of continuously monitoring glucose and ketones at the same time can be provided.
[0010] In the multi-analyte monitoring sensor of the present disclosure, the polymer membrane layer optionally includes a vinyl pyridine polymer, a cross-linking agent, and a modifier, with the mass fraction of the vinyl pyridine polymer in the polymer membrane layer being 80% to 100%. This facilitates the formation of a biocompatible polymer membrane layer that restricts the permeation of glucose and ketones. The polymer membrane can control the amount of glucose and ketones within the linear range of the sensor, thereby improving the sensitivity and accuracy of the sensor.
[0011] In the multi-analyte monitoring sensor of the present disclosure, the polymer film layer optionally includes a first film layer sequentially disposed on the enzyme sensing layer, a transition layer formed on the first film layer, and a second biocompatible film layer formed on the transition layer. This improves the bonding stability of the film layers, thereby enhancing the stability of the sensor.
[0012] In addition, in the multi-analyte monitoring sensor of the present disclosure, optionally, the first membrane layer is formed from a first polymer, the second membrane layer is formed from a second polymer, and the transition layer is formed from a third polymer, wherein the third polymer is a copolymer formed from a first monomer that is identical or similar to the first polymer and a second monomer that is identical or similar to the second polymer. This can improve the bonding stability and mechanical strength of the polymer membrane layers, thereby enhancing the stability of the sensor.
[0013] In addition, in the multi-analyte monitoring sensor of the present disclosure, the first film layer optionally comprises a vinyl pyridine polymer, and the transition layer and the second film layer comprise a vinyl pyridine-styrene copolymer. This can improve the film-forming properties of the film layers and thereby enhance the sensitivity of the sensor.
[0014] In addition, in the multi-analyte monitoring sensor of the present disclosure, optionally, the area of the first analyte enzyme layer is larger than the area of the second analyte enzyme layer. Since the amount of glucose and ketones that can pass through the polymer membrane is different, and the amount of glucose is generally less than the amount of ketones, in this case, by configuring the area of the first analyte enzyme layer to be larger than the area of the second analyte enzyme layer, the contact area between the first analyte enzyme layer and glucose can be increased, thereby minimizing the current difference between the two working electrodes, making the current on the two working electrodes at the same level, reducing the interference of the electric field on the sensor system, and further improving the measurement accuracy of the sensor.
[0015] In addition, in the multi-analyte monitoring sensor of the present disclosure, optionally, the area ratio of the first analyte enzyme layer to the second analyte enzyme layer is 1:1 to 1.5:1. This can improve the reaction sensitivity of the first analyte and more accurately reflect the concentration level of the analyte in the tissue fluid.
[0016] In addition, in the multi-analyte monitoring sensor of the present disclosure, the first analyte enzyme layer and / or the second analyte enzyme layer may optionally be linear. In this case, compared to a multi-point discrete arrangement, a larger enzyme layer can be arranged on a limited working electrode, thereby improving the sensitivity of the sensor.
[0017] In addition, in the multi-analyte monitoring sensor of the present disclosure, optionally, the second analyte enzyme layer includes hydroxybutyrate dehydrogenase, diaphorase, a coenzyme, and an electron mediator. In the second analyte enzyme layer, the mass fraction of hydroxybutyrate dehydrogenase is 10% to 20%, the mass fraction of diaphorase is 5% to 20%, the mass fraction of the coenzyme is 10% to 30%, and the mass fraction of the electron mediator is 10% to 30%. In this case, the reaction sensitivity of the second analyte enzyme layer to β-BHB can be improved. At the same time, by providing a macromolecular electron mediator in the enzyme layer, hydroxybutyrate dehydrogenase can be covalently bound to the electron mediator, thereby further improving stability.
[0018] In addition, in the multi-analyte monitoring sensor of the present disclosure, the sensor optionally further includes a reference electrode and a counter electrode, wherein the first working electrode and the second working electrode are respectively located on opposite sides of the substrate, and the reference electrode and the counter electrode are respectively located on opposite sides of the substrate. In this case, a four-electrode dual-path detection sensor can be formed. Furthermore, placing the four electrodes, two by two, on opposite sides of the substrate can improve substrate utilization while further reducing electric field interference with the sensor system.
[0019] According to the present disclosure, a multi-analyte monitoring sensor can be provided, which can continuously monitor glucose and ketones simultaneously, has a simple manufacturing process, and has high sensitivity and stability. BRIEF DESCRIPTION OF THE DRAWINGS
[0020] The present disclosure will now be explained in further detail, by way of example only, with reference to the accompanying drawings, in which:
[0021] FIG. 1 is a schematic diagram illustrating a multi-analyte monitoring sensor according to an example of the present disclosure.
[0022] FIG. 2A is a schematic front view illustrating a multi-analyte monitoring sensor according to an example of the present disclosure.
[0023] FIG. 2B is a schematic diagram showing the reverse side of a multi-analyte monitoring sensor according to an example of the present disclosure.
[0024] FIG. 3 is a schematic diagram illustrating a polymer film layer according to an example of the present disclosure.
[0025] FIG. 4 is a graph showing a response current-test concentration curve of Example 1 of the blood glucose+blood ketone sensor according to the present disclosure.
[0026] FIG5 is a picture showing a monitoring probe of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.
[0027] FIG6 is a graph showing a response current-test time curve of Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.
[0028] FIG. 7 is a graph showing a response current-test concentration curve of Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.
[0029] FIG8 is a graph showing a glucose / sodium β-hydroxybutyrate response current-time curve of Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.
[0030] FIG. 9 is a graph showing a response current-test concentration curve of Example 3 of the blood glucose+blood ketone sensor according to the present disclosure.
[0031] FIG. 10 is a picture showing a monitoring probe of Comparative Example 1 of the blood glucose + blood ketone sensor according to the present disclosure.
[0032] FIG. 11 is a graph showing a response current-test concentration curve of Comparative Example 1 of the blood glucose+blood ketone sensor according to the present disclosure.
[0033] FIG. 12 is a photograph showing a monitoring probe of Comparative Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.
[0034] FIG. 13 is a graph showing a response current-test time curve of Comparative Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.
[0035] FIG. 14 is a photograph showing a monitoring probe of Comparative Example 3 of the blood glucose + blood ketone sensor according to the present disclosure.
[0036] FIG. 15 is a picture showing a monitoring probe of Comparative Example 3 of the blood glucose + blood ketone sensor according to the present disclosure from another perspective.
[0037] FIG. 16 is a picture showing the monitoring probes of the blood ketone sensor according to Example 1 and Comparative Examples 1-2 of the present disclosure.
[0038] FIG. 17 is a picture showing monitoring probes coated with a polymer film layer according to Example 1 and Comparative Examples 1-2 of the blood ketone sensor of the present disclosure.
[0039] FIG. 18 is a graph showing response current versus test concentration in a linearity test of Example 1 of the blood ketone sensor according to the present disclosure.
[0040] FIG. 19 is a graph showing a response current-test concentration curve of a linearity test of Example 1 of the blood ketone sensor according to the present disclosure.
[0041] FIG. 20 is a graph showing a response current-test concentration curve of a stability test of Example 1 of the blood ketone sensor according to the present disclosure.
[0042] FIG. 21 is a graph showing a response current-test concentration curve of a stability test of Comparative Example 1 of the blood ketone sensor according to the present disclosure.
[0043] FIG. 22 is a graph showing a response current-test concentration curve of Comparative Example 2 of a stability test of the blood ketone sensor according to the present disclosure.
[0044] FIG. 23 is a graph showing response current versus test concentration in a linearity test of Comparative Example 3 of the blood ketone sensor according to the present disclosure.
[0045] FIG. 24 is a photograph showing a working electrode of Comparative Example 4 of the blood ketone sensor according to the present disclosure.
[0046] FIG. 25 is a photograph showing a monitoring probe of a sensor of Comparative Example 4 of the blood ketone sensor according to the present disclosure.
[0047] FIG. 26 is a graph showing a response current-test time curve of the sensor of Comparative Example 4 of the blood ketone sensor according to the present disclosure.
[0048] FIG. 27 is a photograph showing a working electrode of a blood ketone sensor according to Comparative Example 5 of the present disclosure.
[0049] FIG. 28 is a graph showing response current versus test concentration in a linearity test of Comparative Example 5 of the blood ketone sensor according to the present disclosure.
[0050] Description of reference numerals:
[0051] 10…monitoring probe, 11…substrate, 12…first working electrode, 121…first analyte enzyme layer, 13…second working electrode, 131…second analyte enzyme layer, 14…semipermeable membrane, 141…first membrane layer, 142…transition layer, 143…second membrane layer, 15…reference electrode, 16…counter electrode DETAILED DESCRIPTION
[0052] The preferred embodiments of the present disclosure are described in detail below with reference to the accompanying drawings. In the following description, identical components are assigned identical reference numerals, and duplicate descriptions are omitted. In addition, the accompanying drawings are merely schematic, and the proportions of the dimensions of the components and the shapes of the components may differ from the actual ones.
[0053] It should be noted that the terms "including" and "having" and any variations thereof in this disclosure, such as a process, method, system, product or device that includes or has a series of steps or units, are not necessarily limited to those steps or units clearly listed, but may include or have other steps or units that are not clearly listed or are inherent to these processes, methods, products or devices.
[0054] In addition, the subheadings and the like in the following description of this disclosure are not intended to limit the content or scope of this disclosure, but are merely provided as a guide for reading. Such subheadings should not be understood as dividing the content of the article, nor should the content under the subheading be limited to the scope of the subheading.
[0055] The present disclosure relates to a multi-analyte monitoring sensor in one aspect, a semipermeable membrane of a multi-analyte monitoring sensor in a second aspect, and a blood ketone sensor in a third aspect.
[0056] In the present disclosure, the multi-analyte monitoring sensor may also be referred to as a "multi-analyte sensor", "blood glucose and blood ketone continuous monitoring sensor", "blood glucose and blood ketone sensor", "blood glucose + blood ketone sensor", "physiological parameter sensor" or "sensor", "sensing probe", "sensing probe", "implanted probe", etc.
[0057] The sensor disclosed herein can be used to monitor physiological parameters of a host, such as glucose, urea, uric acid, ketone bodies, and a series of amino acid compounds in the host.
[0058] In the present disclosure, the sensor can also be used to detect an object in the host body. The object can be a chemical substance in a body fluid. For example, the object can be one or more of glucose, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase, creatine, creatinine, DNA, fructosamine, glucose, glutamine, growth hormone, hormone, ketone body, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid-stimulating hormone or troponin. In addition, the object can also be a drug in a body fluid. For example, the object can be digitoxin, digoxin, theophylline, warfarin or an antibiotic (such as gentamicin, vancomycin, etc.).
[0059] Hereinafter, the multi-analyte monitoring sensor involved in the first aspect of the present disclosure will be described with reference to the accompanying drawings.
[0060] FIG. 1 is a schematic diagram illustrating a multi-analyte monitoring sensor according to an example of the present disclosure.
[0061] In this embodiment, the sensor 10 can be used to obtain physiological parameter information of the host. In some examples, the sensor 10 can be applied to the host, and the host can obtain its own physiological parameter information by applying the monitoring device 1 to itself. In some examples, the sensor 10 can be mounted on a body surface part such as the host's arm, back, abdomen, waist, leg, etc. where the sensor 10 can be partially implanted to monitor physiological parameters. In some examples, the sensor 10 can be used to be implanted subcutaneously in the host to obtain a sensing signal (e.g., a current signal). In some examples, when the sensor 10 is applied to the host, it can come into contact with tissue fluid or blood in the host's body to measure the level of analyte in the tissue fluid or blood.
[0062] In some examples, the sensor 10 includes a substrate 11 and a working electrode disposed on the substrate. In some examples, there may be multiple working electrodes, each of which may be used to detect a different analyte. Thus, the sensor 10 is capable of monitoring multiple analytes.
[0063] In some examples, the working electrode may include a first working electrode 12 and a second working electrode 13. The first working electrode 12 may be used to detect a first analyte, and the second working electrode 13 may be used to detect a second analyte. Thus, the sensor 10 can monitor two analytes.
[0064] In some examples, the first analyte can be any one of glucose, urea, uric acid, ketone bodies, creatinine, ethanol and lactic acid. In some examples, the second analyte can be any one of glucose, urea, uric acid, ketone bodies, creatinine, ethanol and lactic acid. Among them, ketone bodies (which can be simply referred to as ketones) are a general term for acetoacetic acid, β-hydroxybutyric acid and acetone, which are intermediate products of fatty acid oxidation and decomposition in the liver. In the present invention, the content of ketone bodies can be monitored by detecting any one of acetoacetic acid, β-hydroxybutyric acid and acetone. Preferably, parameters related to ketone body levels can be obtained by monitoring β-hydroxybutyric acid in the host.
[0065] In some examples, the first analyte may be glucose. Thus, the glucose concentration in the body can be monitored. In some examples, the second analyte may be ketone bodies. Thus, the ketone body content in the body can be monitored. It should be noted that, as described above, ketone bodies are a collective term for acetoacetate, β-hydroxybutyrate, and acetone, intermediate products of fatty acid oxidation and decomposition in the liver. Therefore, the second analyte may be any one of acetoacetate, β-hydroxybutyrate, and acetone. Preferably, the second analyte may be β-hydroxybutyrate.
[0066] Hereinafter, the sensor 10 involved in the present disclosure will be described in detail by taking the case where the first analyte is glucose and the second analyte is ketone as an example.
[0067] In some examples, sensor 10 may include an enzyme sensing layer disposed on a working electrode. In examples where the working electrode includes a first working electrode 12 and a second working electrode 13, the enzyme sensing layer may include a first analyte enzyme layer 121 and a second analyte enzyme layer 131. First analyte enzyme layer 121 may be disposed on first working electrode 12, and second analyte enzyme layer 131 may be disposed on second working electrode 13. In this case, by disposing two analyte enzyme layers on the two working electrodes of sensor 10, it is possible to separately detect the concentration levels of two different analytes in tissue fluid.
[0068] In some examples, the sensor 10 may include a polymer membrane layer 14. The polymer membrane layer 14 may be configured to be permeable to both the first and second analytes and to cover the first analyte enzyme layer 121 and the second analyte enzyme layer 131. In this case, the polymer membrane layer 14 can restrict the permeability of both analytes, thereby improving sensor stability. Compared to solutions in which semipermeable membranes permeable to both the first and second analytes are disposed on the first and second analyte enzyme layers 121 and 131, respectively, the polymer membrane 14 of the present invention is permeable to both the first and second analytes, thereby simplifying the fabrication process of the sensor 10 while maintaining the high sensitivity and accuracy of the sensor 10. In some examples, the polymer membrane layer 14 is permeable to both glucose and ketones. In this case, by covering the first analyte enzyme layer 121 and the second analyte enzyme layer 131 with a polymer film layer 14, the permeability of the two analytes can be restricted, which helps improve the stability of the sensor. In addition, due to the small size of the biosensor 10, the precision of the film coating on the surface of the sensor 10 is required to be high. Usually, a dip-pull method is used to cover the surface of the sensor 10 with a film liquid to form a film layer covering the sensor 10. Compared with the solution of providing a semipermeable membrane that is permeable to glucose and ketones on the first analyte enzyme layer 121 and the second analyte enzyme layer 131 respectively, the polymer film 14 in the present invention is permeable to both glucose and ketones, thereby simplifying the manufacturing process of the sensor 10 while maintaining the high sensitivity and accuracy of the sensor 10. Thus, a sensor 10 with a simple manufacturing process and capable of continuous monitoring of glucose and ketones can be provided.
[0069] In some examples, the polymer film layer 14 may have a permeability coefficient for glucose of 1 to 1000. Preferably, the polymer film layer 14 may have a permeability coefficient for glucose of 300 to 800. For example, the polymer film layer 14 may have a permeability coefficient for glucose of 300, 400, 500, 600, 700, or 800. In some examples, the polymer film layer 14 may have a permeability coefficient for ketone of 1 to 1000. Preferably, the polymer film layer 14 may have a permeability coefficient for ketone of 200 to 600. For example, the polymer film layer 14 may have a permeability coefficient for ketone of 200, 300, 400, 500, or 600. The permeability coefficient refers to the difference in concentration between the inside and outside of the polymer film layer. For example, if the permeability coefficient for glucose of the polymer film layer is 500, the concentration of glucose outside the polymer film layer is 500 times the concentration of glucose inside the polymer film layer.
[0070] In some examples, the thickness ratio of the polymer film layer 14 can be adjusted to provide the polymer film layer 14 with different permeability coefficients. In this case, by adjusting the permeability coefficient of the polymer film layer 14, the amount of analyte that passes through can be controlled, making the current generated by the working electrode more accurate, thereby making the sensor 10 more sensitive.
[0071] Figure 2A is a schematic diagram showing the front side of a multi-analyte monitoring sensor according to an example of the present disclosure. Figure 2B is a schematic diagram showing the back side of a multi-analyte monitoring sensor according to an example of the present disclosure.
[0072] In some examples, sensor 10 can be used in conjunction with an electronic system, with the sensor 10 and the electronic system forming a sensing assembly. Specifically, sensor 10 can be electrically connected to the electronic system and partially implanted subcutaneously within a host to acquire a sensing signal indicative of an analyte level and transmit the sensing signal to the electronic system. The electronic system can then process and / or retransmit the sensing signal. In this manner, accurate analyte concentrations within the body can be determined.
[0073] In some examples, the sensor 10 may further include a reference electrode 15 and a counter electrode 16 (see Figures 2A and 2B). In this case, a four-electrode dual-path detection sensor can be formed, i.e., the first working electrode 12, the reference electrode 15, and the counter electrode 16 can form a three-electrode circuit, and the second working electrode 13, the reference electrode 15, and the counter electrode 16 can also form a three-electrode circuit.
[0074] In some examples, a four-electrode, two-way detection sensor may include a first working electrode 12, a second working electrode 13, a reference electrode 15, and a counter electrode 16. The first working electrode 12 forms a first loop with the reference electrode 15 and the counter electrode 16, and the second working electrode 13 forms a second loop with the reference electrode 15 and the counter electrode 16. In this case, the number of electrodes in the sensor can be reduced, thereby reducing the length of the substrate and, in turn, the implantation depth of the sensor 10. Since a deeper implantation produces more noticeable pain, this can reduce the pain of sensor 10 implantation and improve wearing comfort.
[0075] In some examples, the first working electrode 12 and the second working electrode 13 can be respectively located on both sides of the substrate 11, and the reference electrode 15 and the counter electrode 16 are respectively located on both sides of the substrate 11. In this case, arranging the four electrodes in pairs on both sides of the substrate can improve the utilization of the substrate, while optimizing the voltage drop of the sensor electrodes, reducing errors, and further reducing the interference of the electric field on the sensor system. In some examples, since the wearing comfort is related to the implantation depth, the longer the substrate, the greater the implantation depth, and the wearing pain may also increase. Therefore, arranging the four electrodes in pairs on both sides of the substrate can improve the utilization of the substrate. Arranging four electrodes in a limited substrate space can reduce the length of the substrate, thereby improving the wearing comfort.
[0076] In some examples, the reference electrode 15 can form a known and fixed potential difference with the tissue fluid or blood. In this case, the potential difference between the working electrode and the tissue fluid or blood can be measured by the potential difference formed by the reference electrode 15 and the working electrode. As a result, the voltage generated by the working electrode can be obtained more accurately, and the electronic system can automatically adjust and maintain the stability of the voltage at the working electrode according to the preset voltage value, so that the measured current signal can more accurately reflect the analyte concentration level information in the tissue fluid or blood. In some examples, the number of reference electrodes 15 can be one or more, for example, two. In this case, the number of reference electrodes can be adjusted according to the number of working electrodes or the current generated by the working electrodes, so that an accurate current signal can be obtained, thereby improving the sensitivity of the sensor.
[0077] In some examples, the sensor 10 can be divided into an implant portion and a connection portion. The implant portion can be placed under the skin of the host and connected to the electronic system through the connection portion. In this case, by placing the implant portion under the skin of the host and electrically connecting the implant portion to the electronic system through the connection portion, it is possible to facilitate the transmission of the sensing signal obtained by the implant portion to the electronic system. In some examples, the implant portion can be rigid. This can facilitate placement under the skin of the host. In other examples, the implant portion can also be flexible, in which case the host's foreign body sensation can be reduced.
[0078] In some examples, as described above, the sensor 10 may include a first analyte enzyme layer 121. In this case, the first analyte can react in the first analyte enzyme layer 121 to generate a current, and a concentration signal of the first analyte can be obtained.
[0079] In some examples, the first analyte enzyme layer 121 may include glucosidase. Thus, glucose can react in the first analyte enzyme layer, thereby generating a glucose concentration signal. In some examples, in the first analyte enzyme layer 121, the content (mass fraction) of glucosidase can be 40% to 70%. For example, the content (mass fraction) of glucosidase can be 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, or 70%. Thus, it is possible to facilitate the reaction of glucose.
[0080] In some examples, the first analyte enzyme layer 121 can include an electron mediator. In some examples, the electron mediator can be a redox polymer. In some examples, the redox polymer can be a metal redox polymer. In some examples, the metal redox polymer can be selected from at least one of poly(vinylferrocene), quaternized poly(4-vinylpyridine) of ferricyanide, quaternized poly(1-vinylimidazole) of ferricyanide, quaternized poly(4-vinylpyridine) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, an osmium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), an osmium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a ruthenium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), a ruthenium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a cobalt 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), or a cobalt 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine). Thus, metal redox polymers can participate in redox reactions via covalent, coordinate, or ionic bonds.
[0081] In some examples, the content (mass fraction) of the electron mediator in the first analyte enzyme layer 121 can be 10% to 40%. For example, the content (mass fraction) of the electron mediator can be 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, or 40%. Thus, the reaction of the first analyte in the first analyte enzyme layer can be promoted.
[0082] In some examples, the first analyte enzyme layer 121 may include a crosslinker. In some examples, the crosslinker may be PEGDGE. In some examples, the crosslinker may be PEGDGE400. In some examples, the content (mass fraction) of the crosslinker in the first analyte enzyme layer 121 may be 0% to 20%. For example, the content (mass fraction) of the crosslinker may be 0%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, or 20%. This facilitates long-term monitoring by the sensor.
[0083] In some examples, the area of the first analyte enzyme layer 121 can be larger than the area of the second analyte enzyme layer 131. Since the polymer membrane 14 can pass different amounts of glucose and ketones, and generally the amount of glucose is less than the amount of ketones, in this case, by configuring the area of the first analyte enzyme layer 121 to be larger than the area of the second analyte enzyme layer 131, the contact area between the first analyte enzyme layer 121 and glucose can be increased, thereby minimizing the current difference between the two working electrodes, ensuring that the currents on the two working electrodes are at the same level, reducing the interference of the electric field on the sensor 10 system, and further improving the measurement accuracy of the sensor 10.
[0084] In some examples, the area ratio of the first analyte enzyme layer 121 to the second analyte enzyme layer 131 can be greater than 1:1. This can help improve the sensitivity of the sensor 10. In some examples, the area ratio of the first analyte enzyme layer 121 to the second analyte enzyme layer 131 can be less than 1.5:1. This can improve the accuracy of the sensor 10. In some examples, the area ratio of the first analyte enzyme layer 121 to the second analyte enzyme layer 131 can be between 1:1 and 1.5:1. This can improve the reaction sensitivity of the first analyte and accurately reflect the concentration level of the analyte in the tissue fluid. In some examples, the area ratio of the second analyte enzyme layer 131 to the first analyte enzyme layer 121 can be 1:1.5, 1:1.4, 1:1.3, 1:1.2, or 1:1.1. This can more accurately reflect the concentration level of the analyte in the tissue fluid.
[0085] In some examples, the first analyte enzyme layer 121 and / or the second analyte enzyme layer 131 can be linear. This can improve the utilization rate of the substrate and at the same time enhance the sensitivity of the sensor. Due to the limitations of existing processing levels and the small size of the sensor, when a very small analyte enzyme layer is applied to the working electrode of the sensor, it is difficult to directly apply a uniform linear enzyme layer on the electrode surface with the existing processing precision. In some examples of the present disclosure, the enzyme layer solution can be applied to the working electrode by drop coating. The drop-shaped solution applied to the working electrode can diffuse and connect to form a whole linear solution. In this case, compared to the solution of multi-point discrete arrangement, a larger area of enzyme layer can be arranged on the working electrode with a limited area, thereby improving the sensitivity of the sensor 10. In some examples, two adjacent droplets of solution can intersect during drop coating, thereby forming a linear analyte enzyme layer on the working electrode by connecting multiple points into a line. In this case, the multi-point line connection method can reduce the processing difficulty of the sensor 10, thereby forming a linear analyte enzyme layer, and thus improving the utilization rate of the substrate.
[0086] In the present disclosure, "the first analyte enzyme layer 121 and / or the second analyte enzyme layer 131 are linear" can include at least three embodiments: the first analyte enzyme layer 121 is linear, the second analyte enzyme layer 131 is linear, and the first analyte enzyme layer 121 and the second analyte enzyme layer 131 are linear. In the present disclosure, other expressions of "A and / or B" have the same meaning as the above-mentioned examples. In this case, by adjusting the area of the analyte enzyme layer, it can be beneficial to improve the sensitivity and accuracy of the sensor 10 when monitoring two analytes.
[0087] Fig. 3 is a schematic diagram showing the polymer membrane layer 14 according to an example of the present disclosure. In Fig. 3 , the illustration of the analyte enzyme layer is omitted.
[0088] In some examples, the first working electrode 12 may include a base layer 140. This can improve the stability of the sensor 10. In some examples, the base layer 140 is conductive, thereby conducting the current signal generated by the analyte reaction. In some examples, the base layer 140 may be made of at least one material selected from gold, glassy carbon, graphite, silver, silver chloride, palladium, titanium, and iridium. In this case, the base layer 140 can have good conductivity and can inhibit electrochemical reactions in the base layer 140, thereby improving the stability of the base layer 140.
[0089] In some examples, the polymer film layer 14 can cover the base layer 140 of the working electrode (see FIG3 ). This simplifies the film manufacturing process of the sensor 10 , improves the biocompatibility of the sensor 10 , and facilitates the long-term use of the sensor 10 .
[0090] In some examples, the polymer film layer 14 may include a vinylpyridine polymer, thereby facilitating the formation of a polymer film layer 14 that has a restrictive permeation effect on glucose and ketones.
[0091] In some examples, the mass fraction of the vinylpyridine polymer in the polymer film layer 14 is 80% to 100%. This can facilitate the formation of a polymer film layer 14 that has a restrictive permeation effect on glucose and ketones and is biocompatible. The polymer film can control the amount of glucose and ketones within the linear range of the sensor, thereby improving the sensitivity and accuracy of the sensor. In some examples, the mass fraction of the vinylpyridine polymer in the polymer film layer 14 is 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100%. This can facilitate the formation of a stable polymer film layer 14 and enhance the restrictive permeation effect of the polymer film layer 14 on glucose and ketones.
[0092] In some examples, the polymer film layer 14 may further include a crosslinker and a modifier. The crosslinker may be polyethylene glycol diglycidyl ether, and the modifier may be polydimethylsiloxane. This can enhance the stability of the polymer film layer 14 and, in turn, improve the performance of the sensor 10.
[0093] In some examples, the polymer film layer 14 may include a first film layer 141. The first film layer 141 may be disposed on the enzyme sensing layer. This can limit the permeation of analytes in the tissue fluid while preventing the permeation of other interfering substances, thereby improving the reaction efficiency of the enzyme sensing layer and thereby enhancing the sensitivity and stability of the sensor.
[0094] In some examples, the polymer film layer 14 may include a second film layer 143. The second film layer 143 may be biocompatible, thereby reducing inflammation caused by implantation of the sensor 10. In some examples, the second film layer 143 may be disposed on the first film layer 141. In this case, a polymer film layer 14 with both permeation-limiting and biocompatible properties can be formed, thereby improving the sensitivity and stability of the sensor 10.
[0095] In some examples, the polymer film layer 14 may further include a transition layer 142. The transition layer 142 may be disposed between the first film layer 141 and the second film layer 143. This allows for a stable polymer film layer 14. Specifically, in some examples, the polymer film layer 14 may include a first film layer 141 disposed sequentially on the enzyme sensing layer, a transition layer 142 formed on the first film layer 141, and a biocompatible second film layer 143 formed on the transition layer 142. This improves the bonding stability of the polymer film layer 14, thereby enhancing the stability of the sensor 10.
[0096] In some examples, the first film layer 141 is formed from a first type of polymer. In some examples, the first type of polymer may include a water-swellable homopolymer. This can facilitate the first film layer. In some examples, the water-swellable homopolymer may be selected from polystyrene, polyurethane, polyethoxyethyl acrylate, polyethoxypropyl acrylate, poly-2-vinylpyridine, poly-4-vinylpyridine, polyhydroxyethyl methacrylate, and polyhydroxyethyl acrylate. This can create a diffusion-controlled polymer layer, resulting in a fixed analyte concentration ratio on both sides of the polymer film layer, thereby expanding the linear response range of the biosensor.
[0097] In some examples, the second film layer 143 is formed of a second type of polymer. In some examples, the second type of polymer may include a water-soluble polymer. In some examples, the water-soluble polymer may be one selected from polyvinyl pyrrolidone, polyvinyl alcohol, chitosan, carboxymethyl chitosan, chitosan salt, alginic acid, alginate, hyaluronic acid, hyaluronate, cellulose ethers, cellulose esters, polyvinyl pyrrolidone, polyacrylamide, polyacrylic acid, polypropylene alcohol, sodium polystyrene sulfonate, polyethylene glycol, and polyethylene glycol-polypropylene glycol copolymer. Thus, the biocompatibility of the biosensor can be improved.
[0098] In some examples, transition layer 142 is formed from a third polymer. The third polymer is a copolymer formed from a first monomer identical to or similar to the first polymer and a second monomer identical to or similar to the second polymer. This improves the bonding stability and mechanical strength of polymer film layer 14, thereby enhancing the stability of sensor 10. This creates a transition layer with enhanced adhesion to first film layer 141 and second film layer 143, facilitating the formation of polymer film layer 14, thereby expanding the linear response range of sensor 10 and improving its biocompatibility.
[0099] In some examples, the first membrane layer 141 may include a vinylpyridine polymer, thereby forming a membrane layer that has a permeation-limiting effect on two analytes.
[0100] In some examples, the transition layer 142 may include a copolymer of vinyl pyridine and styrene, thereby facilitating the formation of a uniform and stable polymer film layer 14 and thereby improving the stability of the polymer film layer.
[0101] In some examples, the second film layer 143 may include a copolymer of vinyl pyridine and styrene, thereby improving the film-forming performance of the polymer film layer 14 and further enhancing the sensitivity of the sensor 10 .
[0102] In some examples, the second analyte enzyme layer 131 may include hydroxybutyrate dehydrogenase. In this case, hydroxybutyrate in the tissue fluid can react under the action of hydroxybutyrate dehydrogenase, thereby obtaining the hydroxybutyrate concentration level through the signal generated by the reaction. The hydroxybutyrate concentration level can then be used to map the concentration of ketone bodies in the tissue fluid. In some examples, the hydroxybutyrate dehydrogenase content in the second analyte enzyme layer 131 may be 10% to 20%. For example, the hydroxybutyrate dehydrogenase content may be 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, or 20%. This can promote the redox reaction of ketones in the second analyte enzyme layer 131.
[0103] In some examples, the second analyte enzyme layer 131 may include diaphorase. In this case, the diaphorase can transfer electrons generated by the β-BHB reaction. In some examples, the diaphorase content in the second analyte enzyme layer 131 may be 5% to 20%. For example, the diaphorase content may be 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, or 20%. This can promote the reaction of the second analyte enzyme layer 131 and improve the efficiency of electron transfer in the working electrode.
[0104] In some examples, the second analyte enzyme layer 131 may include a coenzyme. This can promote the oxidation of hydroxybutyrate dehydrogenase, thereby transferring electrons generated by the β-BHB reaction. In some examples, the coenzyme content in the second analyte enzyme layer 131 can be 10% to 30%. For example, the coenzyme content can be 10%, 12%, 14%, 15%, 16%, 18%, 19%, 20%, 21%, 22%, 25%, 26%, 27%, 28%, 29%, or 30%. This can promote the redox reaction between hydroxybutyrate dehydrogenase and β-BHB.
[0105] In some examples, the second analyte enzyme layer 131 can include an electron mediator. In some examples, the electron mediator can be a redox polymer. In some examples, the redox polymer can be a metal redox polymer. In some examples, the metal redox polymer can be selected from at least one of poly(vinylferrocene), quaternized poly(4-vinylpyridine) of ferricyanide, quaternized poly(1-vinylimidazole) of ferricyanide, quaternized poly(4-vinylpyridine) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, an osmium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), an osmium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a ruthenium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), a ruthenium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a cobalt 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), or a cobalt 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine). Thus, the metal redox polymer can participate in the redox reaction through covalent bonds, coordination bonds, or ionic bonds, and can promote the transfer of electrons to the working electrode, thereby generating a current signal of the second analyte concentration. In some examples, the content of the electron mediator in the second analyte enzyme layer 131 can be 10% to 30%. For example, the content of the electron mediator can be 10%, 12%, 14%, 15%, 16%, 18%, 19%, 20%, 21%, 22%, 25%, 26%, 27%, 28%, 29%, or 30%. In this case, the reaction sensitivity of the second analyte enzyme layer 131 to β-BHB can be improved. At the same time, by providing a macromolecular electron mediator in the enzyme layer, the hydroxybutyrate dehydrogenase can be covalently bound to the electron mediator, thereby further improving stability.
[0106] According to the first aspect of the present disclosure, a multi-analyte monitoring sensor can be provided, which can continuously monitor glucose and ketones simultaneously, has a simple manufacturing process, and has high sensitivity and stability.
[0107] The second aspect of the present disclosure relates to a semipermeable membrane for a multi-analyte monitoring sensor. The semipermeable membrane of the multi-analyte monitoring sensor of the second aspect of the present disclosure is consistent with the polymer membrane layer 14 of the sensor 10 of the first aspect of the present disclosure. The structure of the polymer membrane layer 14, the configuration of its various components and parameters, and the preparation method thereof can be found in the description above and will not be repeated here.
[0108] In the second aspect of the present disclosure, a semipermeable membrane with high stability and capable of limiting the permeation of both glucose and ketones can be provided. The semipermeable membrane covering the electrodes of the multi-analyte sensor 10 can help improve the sensitivity of the sensor 10.
[0109] The third aspect of the present disclosure relates to a blood ketone sensor. The blood ketone sensor involved in the third aspect of the present disclosure is basically the same as the sensor 10 involved in the first aspect of the present disclosure, except that the first working electrode and the first analyte enzyme layer provided on the first working electrode are removed from the sensor 10 involved in the first aspect, and the second working electrode and the second analyte enzyme layer (i.e., the enzyme layer for detecting ketones) for analyzing ketones are retained. The other parts are consistent with the sensor 10 involved in the first aspect and are not repeated here. In some examples, in the blood ketone sensor, the second working electrode 13 and the reference electrode 15 can be provided on the same side of the substrate 11, and the counter electrode 16 can be provided on the other side of the substrate 11. In this way, the utilization rate of the substrate can be improved. The blood ketone sensor involved in the third aspect of the present disclosure can be used to measure the ketone body level in the host body.
[0110] Hereinafter, the multi-analyte monitoring sensor and the blood ketone sensor provided by the present disclosure will be described in detail with reference to the examples and comparative examples, but they should not be construed as limiting the scope of protection of the present disclosure.
[0111] [Blood glucose + blood ketone sensor]
[0112] Example 1
[0113] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.
[0114] Next, prepare the ketone body sensitive layer reagent components (osmium coordinated metal polymer, β-hydroxybutyrate dehydrogenase, diaphorase, NAD + , stabilizer, cross-linking agent), dissolve each substance in a buffer solvent in a HEPES buffer according to the concentration parameters in the table to obtain a β-hydroxybutyrate sensitive layer solution.
[0115] Subsequently, a glucose-sensitive layer solution was prepared according to the concentration of osmium coordinated metal polymer of 10 mg / mL, glucose oxidase (GOD) of 12.5 mg / mL, and cross-linking agent PEGDGE of 2.5 mg / mL.
[0116] The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of approximately 0.27 mm. 2 The ketone body sensing layer area is about 0.27mm 2 ; That is, the area ratio of blood ketone to blood glucose sensing layer is 1:1; solidification is performed to obtain an electrode containing a dual-component response sensing layer of glucose and ketone bodies.
[0117] Table 1. Ketone body sensitive layer reagent components
[0118] Then, ethanol was prepared as a solvent, and polyvinylpyridine and PEGDGE were prepared according to Table 2 to obtain a diffusion-limiting membrane solution. The diffusion-limiting membrane solution was applied to the electrode deposited with the sensitive layer reagent to prepare a dual-component monitoring working electrode with a membrane layer of approximately 25 μm.
[0119] Table 2. Diffusion-limiting membrane solution composition
[0120] Prepare an 80% ethanol aqueous solution, and mix poly (4-vinylpyridine-co-polystyrene) and PEGDGE at corresponding concentrations according to Table 3 to obtain a compatible membrane solution. Apply the compatible membrane solution to the diffusion-limiting membrane of the working electrode to produce a working electrode containing an approximately 15 μm compatible membrane layer.
[0121] Table 3. Compatibility membrane solution composition
[0122] Prepare an 80% ethanol aqueous solution, and prepare (poly (4-vinylpyridine-g-polyethylene glycol))-co-polystyrene and PEGDGE to corresponding concentrations according to Table 4 to obtain a biocompatible membrane solution; apply the biocompatible membrane solution to the compatible membrane of the working electrode to produce a biocompatible membrane layer containing approximately 15 microns, resulting in a working electrode with a total film thickness of approximately 56 microns.
[0123] Table 4. Biocompatible membrane solution composition
[0124] The sensor of Example 1 was immersed in a standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached, and the response current was measured simultaneously with corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration.
[0125] FIG4 is a graph showing the response current-test concentration curve of Example 1 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG4 , the response of the dual-component sensor of Example 1 to glucose and sodium β-hydroxybutyrate exhibits good linearity. Specifically, it can be seen that the linear response current curve R 2 Both are greater than 0.996, indicating a good linear relationship. The sensitivity of the glucose working electrode is 0.79nA / mM, and the sensitivity of the ketone body working electrode is 2.35nA / mM.
[0126] Example 2
[0127] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.
[0128] Next, a β-hydroxybutyrate sensitive layer solution and a glucose sensitive layer solution were prepared using the same formula as in Example 1, wherein the metal polymer was a ruthenium coordinated metal polymer. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, each forming a linear pattern, wherein the glucose sensing layer had an area of approximately 0.3 mm. 2 The ketone body sensing layer area is about 0.27mm 2 ; solidification is performed to obtain an electrode containing a dual-component responsive sensing layer of glucose and ketone bodies.
[0129] The diffusion limiting membrane, the compatibility membrane and the biocompatible membrane were coated in the same manner as in Example 1 to obtain the sensor of Example 2 having a blood glucose to blood ketone sensing layer area ratio of 1.11:1.
[0130] FIG5 is a picture showing a monitoring probe of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.
[0131] The sensor of Example 2 was immersed in a standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached, and the response current was measured simultaneously with corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration.
[0132] FIG6 is a graph showing the response current versus test time of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure. FIG7 is a graph showing the response current versus test concentration of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure. As shown in FIG6 and FIG7 , the response of the dual-component sensor of Example 2 to glucose and sodium β-hydroxybutyrate exhibits good linearity. Specifically, as shown in FIG7 , the linear response current curve R of the sensor to glucose and sodium β-hydroxybutyrate is 2 Both were greater than 0.99, indicating a good linear relationship. The sensitivity of the glucose working electrode was 1.10 nA / mM, and the sensitivity of the ketone body working electrode was 2.43 nA / mM.
[0133] The sensor of Example 2 was immersed in standard PBS buffer (pH 7.4) at 37°C for 336 hours (14 days). FIG8 shows the glucose / sodium β-hydroxybutyrate response current-time curve of Example 2 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG8 , both current signals of the sensor remained stable during the test period from day 0 to day 14.
[0134] Example 3
[0135] A monitoring probe with dual working electrodes was prepared in the same manner as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of approximately 0.39 mm. 2 The ketone body sensing layer area is about 0.26mm 2 ; That is, the area ratio of blood ketone to blood glucose sensing layer is 1:1.5; solidification is performed to obtain an electrode containing a dual-component response sensing layer of glucose and ketone bodies.
[0136] Next, the diffusion limiting membrane, the compatibility membrane, and the biocompatible membrane were coated in the same manner as in Example 1 to obtain the sensor of Example 3 having a blood ketone to blood glucose sensing layer area ratio of 1:1.5.
[0137] The sensor of Example 3 was immersed in a standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached, and the response current was measured simultaneously with corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration.
[0138] FIG9 is a graph showing the response current-test concentration curve of Example 3 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG9 , the response of the dual-component sensor of Example 3 to glucose and sodium β-hydroxybutyrate shows good linearity. Specifically, the linear response current curve R of the sensor to glucose and sodium β-hydroxybutyrate is 2 Both are greater than 0.997, indicating a good linear relationship. The sensitivity of the glucose working electrode is 1.22nA / mM, and the sensitivity of the ketone body working electrode is 2.52nA / mM.
[0139] Comparative Example 1
[0140] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.
[0141] Next, a β-hydroxybutyrate sensitive layer solution and a glucose sensitive layer solution were prepared with the same formula as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of approximately 0.3 mm. 2 The ketone body sensing layer area is about 0.45mm 2 , that is, the area ratio of the glucose enzyme layer to the ketone body enzyme layer is 1:1.5; solidification is performed to obtain an electrode containing a dual-component response sensing layer of glucose and ketone bodies.
[0142] Then, the two-component response electrode obtained above was coated according to the same three-layer film formulation as in Example 1, and finally a two-component sensor with a film thickness of about 57 microns was obtained.
[0143] FIG. 10 is a picture showing a monitoring probe of Comparative Example 1 of the blood glucose + blood ketone sensor according to the present disclosure.
[0144] The sensor of Comparative Example 1 was immersed in a standard PBS buffer (pH 7.4) at 37° C.; a working voltage was applied relative to the reference electrode until a constant background current was reached, and the response current was measured under the corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2 mM / 1 mM, 5 mM / 2 mM, 10 mM / 3 mM, 15 mM / 4 mM, 20 mM / 6 mM, and 25 mM / 8 mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration;
[0145] FIG. 11 is a graph showing a response current-test concentration curve of Comparative Example 1 of the blood glucose+blood ketone sensor according to the present disclosure.
[0146] The current response of the dual-component sensor of Comparative Example 1 to the concentration of sodium β-hydroxybutyrate showed good linearity, but the current response to the concentration of glucose was poor. Specifically, as shown in FIG11 , the linear curve R of the response current of the sensor to glucose and sodium β-hydroxybutyrate is shown in FIG11 . 2 They are 0.877 and 0.995 respectively, which shows that the glucose sensor is not linear in the range of 0-25mM. This may be because when responding to high concentrations, the amount of ketone body reaction is large, and the product will affect the response of the working electrode on the glucose side, resulting in the non-linear problem of high glucose concentration.
[0147] Comparative Example 2
[0148] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.
[0149] Next, the β-hydroxybutyrate sensitive layer solution and the glucose sensitive layer solution were prepared with the same formula as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of approximately 0.3 mm. 2 The ketone body sensing layer area is about 0.27mm 2 ; solidification is performed to obtain an electrode containing a dual-component responsive sensing layer of glucose and ketone bodies.
[0150] Next, an 80% ethanol aqueous solution was prepared as the solvent, and polyvinylpyridine-b-polystyrene and PEGDGE were prepared into alcohol solutions of corresponding concentrations according to Table 5 to obtain a membrane solution. This membrane solution was then applied to the electrode deposited with the sensitive layer reagent to produce a dual-component monitoring working electrode containing an approximately 60-micron membrane layer.
[0151] Table 5. Diffusion-limiting membrane solution composition
[0152] FIG. 12 is a photograph showing a monitoring probe of Comparative Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.
[0153] The sensor from Comparative Example 2 was immersed in standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached. The response current was then measured in the presence of glucose and sodium β-hydroxybutyrate at corresponding concentrations. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, with the former indicating glucose concentration and the latter indicating sodium β-hydroxybutyrate concentration.
[0154] FIG13 is a graph showing the response current-test time curve of Comparative Example 2 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG13 , the response of the dual-component sensor of Comparative Example 2 to glucose and sodium β-hydroxybutyrate shows good linearity. Specifically, the linear response current curve R of the sensor to glucose and sodium β-hydroxybutyrate is 2 Both values were greater than 0.99, indicating a good linear relationship. The sensitivity of the glucose working electrode was 0.30 nA / mM, and that of the ketone body working electrode was 0.73 nA / mM. However, compared with Example 2, the sensitivity of both electrodes in Comparative Example 2 was lower, indicating that the addition of the compatibility and biocompatible membrane layers significantly improved the sensitivity of the electrodes.
[0155] Comparative Example 3
[0156] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.
[0157] Next, the β-hydroxybutyrate sensitive layer solution and the glucose sensitive layer solution were prepared with the same formula as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of approximately 0.3 mm. 2 The ketone body sensing layer area is about 0.27mm 2 ; solidification is performed to obtain an electrode containing a dual-component responsive sensing layer of glucose and ketone bodies.
[0158] Next, ethanol was prepared as a solvent, and polyvinylpyridine and PEGDGE were mixed with alcohol solutions of corresponding concentrations according to Table 6 to obtain a diffusion-limiting membrane solution. This diffusion-limiting membrane solution was then applied to the electrode deposited with the sensitive layer reagent to produce a dual-component monitoring working electrode with a membrane layer of approximately 35 microns.
[0159] Table 6 Composition of diffusion limiting membrane solution
[0160] Finally, an 80% ethanol aqueous solution was prepared, and (poly-4-vinylpyridine-g-polyethylene glycol)-co-polystyrene and PEGDGE were prepared at corresponding concentrations according to Table 7 to obtain a biocompatible membrane solution; the biocompatible membrane solution was applied to the diffusion-limiting membrane of the working electrode to produce a working electrode containing a biocompatible membrane layer of approximately 25 microns and a total film thickness of approximately 60 microns.
[0161] Table 7 Biocompatible membrane solution composition
[0162] Figure 14 is a picture showing the monitoring probe of comparative example 3 of the blood glucose + blood ketone sensor according to the present disclosure. Figure 15 is a picture showing the monitoring probe of comparative example 3 of the blood glucose + blood ketone sensor according to the present disclosure from another perspective.
[0163] As shown in FIG14 and FIG15 , it can be seen that in the absence of the compatible membrane layer, the semipermeable membrane of the prepared sensor is wrinkled and has uneven thickness from top to bottom, which is not conducive to the preparation of a highly consistent sensor.
[0164] [Blood Ketone Sensor]
[0165] Example 1, Comparative Examples 1-2
[0166] First, prepare a monitoring probe with a working electrode.
[0167] Next, according to Table 8, the sensitive layer reagent raw materials of each blood ketone sensor embodiment and comparative example were prepared (ruthenium coordinated metal polymer, β-hydroxybutyrate dehydrogenase, diaphorase, NAD +, stabilizer, cross-linking agent, etc., dissolve each substance in the corresponding solvent buffer solvent according to the concentration parameters in the table, and ultrasonically vibrate to completely dissolve it to obtain the β-hydroxybutyric acid sensitive layer solution of each embodiment.
[0168] The β-hydroxybutyric acid sensitive layer solution is deposited on the working electrode to form a linear pattern with a width of about 160 microns and a length of about 2.1 mm; and the solution is solidified to obtain an enzyme sensing layer.
[0169] Table 8. Examples of Blood Ketone Sensors
[0170] FIG. 16 is a picture showing the monitoring probes of the blood ketone sensor according to Example 1 and Comparative Examples 1-2 of the present disclosure.
[0171] Then, pure ethanol was prepared as a solvent, and polyvinylpyridine, polydimethylsiloxane, and PEGDGE were mixed with alcohol solutions of corresponding concentrations according to Table 9 to obtain a diffusion-limiting membrane solution. The diffusion-limiting membrane solution was then coated onto the working electrode on which the β-hydroxybutyrate-sensitive layer solution had been deposited, to produce a working electrode containing an approximately 20-micron diffusion-limiting membrane layer.
[0172] Table 9. Diffusion-limiting membrane solution composition
[0173] Prepare an 80% ethanol aqueous solution and mix poly (4-vinylpyridine-co-polystyrene) and PEGDGE in corresponding concentrations according to Table 10 to obtain a compatible membrane solution. Coat the working electrode coated with the diffusion-limiting layer with the compatible membrane solution to produce a working electrode containing an approximately 15 μm compatible membrane layer.
[0174] Table 10. Compatibility membrane solution composition
[0175] Prepare an 80% ethanol aqueous solution, and prepare (poly (4-vinylpyridine-g-polyethylene glycol))-co-polystyrene and PEGDGE to corresponding concentrations according to Table 11 to obtain a biocompatible membrane solution; coat the working electrode coated with the compatible membrane layer with the biocompatible membrane solution to produce a working electrode containing a biocompatible membrane layer of approximately 15 microns and a total film thickness of 50 microns.
[0176] Table 11. Biocompatible membrane solution composition
[0177] FIG. 17 is a picture showing monitoring probes coated with a polymer film layer according to Example 1 and Comparative Examples 1-2 of the blood ketone sensor of the present disclosure.
[0178] Finally, the linearity and stability tests of the ketone body biosensors obtained in Example 1 and Comparative Examples 1-2 were conducted:
[0179] (1) Linearity test:
[0180] The ketone body biosensor was immersed in standard PBS buffer (pH 7.4) at 37°C; an operating voltage was applied until the ketone body biosensor reached a constant background current, and sodium β-hydroxybutyrate at concentrations of 0mM, 1mM, 2mM, 3mM, 4mM, 6mM, and 8mM was added to the solution to measure the linearity of the reaction. After each addition of sodium β-hydroxybutyrate, the solution was allowed to equilibrate for 10 minutes, and the solution was continuously stirred during the measurement process to ensure a uniform concentration.
[0181] Figure 18 is a graph showing the response current versus test concentration of the linearity test of Example 1 of the blood ketone sensor according to the present disclosure. Figure 19 is a graph showing the response current versus test concentration of the linearity test of Example 1 of the blood ketone sensor according to the present disclosure.
[0182] As shown in Figures 18 and 19, the ketone body biosensor of blood ketone sensor Example 1 exhibits good linearity in response to glucose. Specifically, the glucose sensor in Example 1 has a good linear correlation between the concentration of sodium β-hydroxybutyrate and the response current in the range of 0 mM to 8 mM.
[0183] (2) Stability test:
[0184] The ketone body biosensor was immersed in 3 mM sodium β-hydroxybutyrate (PBS buffer pH 7.4 as solvent) at 37°C and measured continuously for 14 days.
[0185] FIG20 is a graph showing a response current versus test concentration curve in a stability test of Example 1 of the blood ketone sensor according to the present disclosure. FIG21 is a graph showing a response current versus test concentration curve in a stability test of Comparative Example 1 of the blood ketone sensor according to the present disclosure. FIG22 is a graph showing a response current versus test concentration curve in a stability test of Comparative Example 2 of the blood ketone sensor according to the present disclosure.
[0186] As shown in Figures 20-22, Comparative Example 1 failed to maintain stability for 14 days at 37°C, and performance began to decline on the fifth day. However, both Example 1 and Comparative Example 2 maintained stability for 14 days because a stabilizer was added to the enzyme sensing layer, achieving longer-term stability for the ketone body sensor. The higher response value of Example 1 than that of Comparative Example 2 indicates that using HEPES buffer as the solvent for the sensitive layer reagent is superior to using PBS buffer as the solvent for the sensitive layer reagent.
[0187] Comparative Example 3
[0188] A monitoring probe having a working electrode was prepared in the same manner as in Example 1 for blood ketones, and an enzyme sensing layer was provided on the working electrode to obtain a sensor without a semipermeable membrane.
[0189] The sensor of Comparative Example 3 was exposed to a solution containing 1 mM sodium β-hydroxybutyrate in a standard PBS buffer (pH 7.4) at 37° C. under energy for 1 hour.
[0190] FIG. 23 is a graph showing response current versus test concentration in a linearity test of Comparative Example 3 of the blood ketone sensor according to the present disclosure.
[0191] As shown in Figure 23, over the course of a one-hour test, the current signal generated by the sensor gradually decreased from 240 nA to below 155 nA, indicating poor stability. These results indicate that sensors without a semipermeable membrane exhibit poor stability when measuring the concentration of sodium β-hydroxybutyrate solutions.
[0192] Comparative Example 4
[0193] A monitoring probe having a working electrode was prepared in the same manner as in the blood ketone comparative example 4, and an enzyme sensing layer was provided on the working electrode to obtain a sensor without a semipermeable membrane.
[0194] Prepare an 80% ethanol-water solution and mix poly (4-vinylpyridine-co-polystyrene) and PEGDGE in corresponding concentrations as shown in the table below to obtain an inner membrane solution. Coat the inner membrane solution onto the working electrode having the enzyme sensing layer to produce a working electrode having an approximately 35 μm poly (4-vinylpyridine-b-polystyrene) membrane layer.
[0195] Table 12 Inner membrane solution composition
[0196] FIG. 24 is a photograph showing a working electrode of Comparative Example 4 of the blood ketone sensor according to the present disclosure.
[0197] Prepare an 80% ethanol aqueous solution, and configure (poly-4-vinylpyridine-g-polyethylene glycol)-co-polystyrene and PEGDGE to corresponding concentration solutions according to Table 13 to obtain an outer membrane solution; coat the working electrode coated with the inner membrane with the outer membrane solution to prepare a working electrode containing an outer membrane of about 15 microns and a total membrane thickness of 50 microns.
[0198] Table 13 Outer membrane solution composition
[0199] FIG. 25 is a photograph showing a monitoring probe of a sensor of Comparative Example 4 of the blood ketone sensor according to the present disclosure.
[0200] Finally, the obtained ketone body sensor was subjected to a stability test; that is, the comparative example 4 ketone body biosensor was immersed in 3 mM sodium β-hydroxybutyrate (PBS buffer pH 7.4 as solvent) at 37° C.; and the measurement was continued for 3 days.
[0201] FIG. 26 is a graph showing a response current-test time curve of the sensor of Comparative Example 4 of the blood ketone sensor according to the present disclosure.
[0202] As shown in Figure 26, the initial response current of the sensor in comparative example 4 was 15.6 nA. After three days, the sensor response current decreased to 11.2 nA, a total decrease of 28.2%, and an average daily decrease of 9.4% / day. This shows that the sensor coated only with poly (4-vinylpyridine)-b-polystyrene and (poly (4-vinylpyridine)-g-polyethylene glycol)-co-polystyrene film has poor stability.
[0203] The main reason is that the membrane layer combination has a higher permeability to sodium β-hydroxybutyrate than that of blood ketone Example 1, indicating that the diffusion restriction effect of the membrane is not strong enough to reduce the permeability of sodium β-hydroxybutyrate, and the small molecule escape effect of the enzyme layer is restricted, resulting in its poor stability.
[0204] Comparative Example 5
[0205] First, prepare a monitoring probe with a working electrode.
[0206] The corresponding reagents were prepared according to the same enzyme layer formula as in Example 1 for blood ketones. The β-hydroxybutyrate sensitive layer solution was drop-coated on the working electrode using an ultra-micro pipetting robot to form 6 independent dot patterns with a dot diameter of 150 μm. The solution was then cured to obtain an enzyme sensor having a 6-dot pattern.
[0207] FIG. 27 is a photograph showing a working electrode of a blood ketone sensor according to Comparative Example 5 of the present disclosure.
[0208] Then, the 6-dot pattern enzyme sensor was coated with a film layer according to the same film layer coating scheme as in Example 1 for blood ketones to obtain the ketone body sensor of Comparative Example 5.
[0209] Finally, the obtained comparative example 5 ketone body sensor was subjected to a linearity test: the ketone body biosensor was immersed in a standard PBS buffer (pH 7.4) at 37°C; an operating voltage was applied until the ketone body biosensor reached a constant background current, and sodium β-hydroxybutyrate at concentrations of 1mM, 2mM, 3mM, 4mM, 5mM, 6mM, 7mM, and 8mM was added to the solution to measure the linearity of the reaction. After each addition of sodium β-hydroxybutyrate, the solution was continuously stirred during the measurement process to make its concentration uniform.
[0210] FIG. 28 is a graph showing response current versus test concentration in a linearity test of Comparative Example 5 of the blood ketone sensor according to the present disclosure.
[0211] As shown in FIG28 , it can be seen that its response to sodium β-hydroxybutyrate shows good linearity in the concentration range of 0-8 mM, but its response sensitivity is low, that is, the slope of the linear fitting curve is 0.677 nA / mM. However, the sensitivity of the sensor in Example 1 is 2.08 nA / mM, and that of Comparative Example 5 is only 32.5% of that in Example 1. This is because the area of the enzyme layer in Comparative Example 5 is small, resulting in a low reaction area with sodium β-hydroxybutyrate that permeates the membrane layer. This indicates that increasing the area of the enzyme layer can effectively increase the sensitivity of the sensor.
[0212] Various examples of the present disclosure have been described above in the detailed description. Although these descriptions directly describe the above examples, it should be understood that modifications and / or variations of the specific examples shown and described herein may be conceivable to those skilled in the art. Any such modifications or variations that fall within the scope of this specification are also intended to be included therein. Unless otherwise specified, it is the inventor's intention that the terms in the specification and claims be given their ordinary and customary meanings as given to those of ordinary skill in the art.
Claims
1. A multi-analyte monitoring sensor, characterized in that: The sensor comprises a substrate, a working electrode disposed on the substrate, an enzyme sensing layer disposed on the working electrode, and a polymer film layer disposed on the enzyme sensing layer. The working electrode comprises a first working electrode and a second working electrode; The enzyme sensing layer comprises a first analyte enzyme layer and a second analyte enzyme layer, the first analyte enzyme layer is disposed on the first working electrode, the second analyte enzyme layer is disposed on the second working electrode, the first analyte is glucose, and the second analyte is ketone; The polymer membrane layer is permeable to the first analyte and the second analyte and covers the first analyte enzyme layer and the second analyte enzyme layer.
2. The multi-analyte monitoring sensor according to claim 1, characterized in that: The polymer film layer comprises a vinyl pyridine polymer, a cross-linking agent, and a regulator, and the mass fraction of the vinyl pyridine polymer in the polymer film layer is 80% to 100%.
3. The multi-analyte monitoring sensor according to claim 1, characterized in that: The polymer film layer comprises a first film layer which is sequentially arranged on the enzyme sensing layer, a transition layer which is formed on the first film layer, and a second film layer which is formed on the transition layer and has biocompatibility.
4. The multi-analyte monitoring sensor according to claim 3, characterized in that: The first film layer is formed by a first type of polymer, the second film layer is formed by a second type of polymer, and the transition layer is formed by a third type of polymer, wherein the third type of polymer is a copolymer formed by a first monomer that is the same as or similar to the first type of polymer and a second monomer that is the same as or similar to the second type of polymer.
5. The multi-analyte monitoring sensor according to claim 3 or 4, characterized in that: The first film layer includes a vinyl pyridine polymer, and the transition layer and the second film layer include a copolymer of vinyl pyridine and styrene.
6. The multi-analyte monitoring sensor according to claim 1, characterized in that: The area of the first analyte enzyme layer is greater than the area of the second analyte enzyme layer.
7. The multi-analyte monitoring sensor according to claim 1, characterized in that: The area ratio of the first analyte enzyme layer to the second analyte enzyme layer is 1:1 to 1.5:
1.
8. The multi-analyte monitoring sensor according to claim 1, characterized in that: The first analyte enzyme layer and / or the second analyte enzyme layer are in a linear shape.
9. The multi-analyte monitoring sensor according to claim 1, characterized in that: The second analyte enzyme layer includes hydroxybutyrate dehydrogenase, diaphorase, coenzyme, and electron mediator. In the second analyte enzyme layer, the mass fraction of hydroxybutyrate dehydrogenase is 10% to 20%, the mass fraction of diaphorase is 5% to 20%, the mass fraction of coenzyme is 10% to 30%, and the mass fraction of the electron mediator is 10% to 30%.
10. The multi-analyte monitoring sensor according to claim 1, characterized in that: The sensor further includes a reference electrode and a counter electrode. The first working electrode and the second working electrode are respectively located on two sides of the substrate. The reference electrode and the counter electrode are respectively located on two sides of the substrate.
Citation Information
Patent Citations
Heterocyclic nitrogen containing polymer coated analyte monitoring device and methods of use
CN101686809A
Glucose monitoring probe
CN110044986A
Lactate sensors and associated methods
CN111989042A
Analyte sensors and sensing methods featuring dual detection of glucose and ketones
CN113329689A
Analyte Sensors Having a Membrane with Low Temperature Sensitivity
US20120296186A1
Cited By
Enzyme dripping method of microsensor and microsensor
CN120121684A
A microsensor enzyme method and microsensor
CN120121684B
